Oliver WisemanMA FRCS (Urol)

Consultant Urologist

Oliver Wiseman

Lead Clinician for  urinary stone disease. Training Programme Director for East of England 

 

Direct:
+44 (0)1223 586593email
NHS Secretary:
+44 (0)1223 216344email
Private Secretary:
+44 01223 370962 (Cambridge Urology Partnership)email
Special Interests:

Urinary stone disease

Male factor infertility

Oliver is the lead clinician for urinary stone disease. His other area of interest is male infertility.

Oliver qualified in medicine from The University of Cambridge. He did his specialist training in London, and has also worked in France, Sweden and New Zealand.

He has published widely on stone disease, and his main research interests are in the development of PROMs for stone disease, and developing and recruiting to multicentre studies looking at outcomes from stone surgery.

He is the Training Programme Director for urology registrars in the East of England. He has run and been invited to participate in national and international training conferences and training courses on stone surgery and male infertility.

He is a trustee and committee member of British Association of Urological Surgeons (BAUS), is on the committee of the BAUS Section of Endourology, and was on the organising committee for the World Congress of Endourology, which was held in London in 2015. He is the BAUS lead for the publication of national outcomes from PCNL.

He has been awarded the Golden Telescope by The British Association of Urological Surgeons in recognition of his achievements, and also been invited to be a committee member of the Awards and Medal Committee of The Endourological Society.

 

 

Publications

 

1. Première évaluation clinique d’un nouvel urétéroscope souple à usage unique (LithoVue™) : étude préliminaire prospective européenne multicentrique.

Doizi S, Kamphuis G, Giusti G, Hovgaard Andreassen K, Knoll T, Osther P, Scoffone C, Pérez-Fentes D, Proietti S, Wiseman O, De la Rosette J, Traxer O.

Prog Urol. 2016 Nov;26(13):754-755. doi: 10.1016/j.purol.2016.07.176. French. No abstract available.

 

2. Alpha blockers should no longer be used for ureteric stones.

Wiseman OJ, McClinton S.

Int J Surg. 2016 Dec;36(Pt D):657-659. doi: 10.1016/j.ijsu.2016.11.006. Review.

 

 

3. First clinical evaluation of a new single-use flexible ureteroscope (LithoVue™): a European prospective multicentric feasibility study.

Doizi S, Kamphuis G, Giusti G, Andreassen KH, Knoll T, Osther PJ, Scoffone C, Pérez-Fentes D, Proietti S, Wiseman O, de la Rosette J, Traxer O.

World J Urol. 2016 Sep 26. [Epub ahead of print]

 

 

4. Which Is Better? “Live” Surgical Broadcasts vs “As-Live” Surgical Broadcasts.

Phan YC, Segaran S, Wiseman O, James P, Clayman R, Smith A, Rane A.

J Endourol. 2016 Sep;30(9):1022-8. doi: 10.1089/end.2016.0165.

 

 

5. Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experience.

Dev HS, Poo S, Armitage J, Wiseman O, Shah N, Al-Hayek S.

World J Urol. 2016 Apr 29. [Epub ahead of print]

 

 

6. In Vitro Assessment of Three Clinical Lithotripters Employing Different Shock Wave Generators.

Faragher SR, Cleveland RO, Kumar S, Wiseman OJ, Turney BW.

J Endourol. 2016 May;30(5):560-5. doi: 10.1089/end.2015.0662.

 

7. Assessment of Stone Complexity for PCNL: A Systematic Review of the Literature, How Best Can We Record Stone Complexity in PCNL?

Withington J, Armitage J, Finch W, Wiseman O, Glass J, Burgess N.

J Endourol. 2016 Jan;30(1):13-23. doi: 10.1089/end.2015.0278. Review.

 

8. A man with rust coloured urine and normocytic anaemia.

Case S, Johnston TJ, O’Sullivan M, Thomas W, Wiseman OJ.

BMJ. 2015 May 1;350:h2113. doi: 10.1136/bmj.h2113. 

 

9. Hospital Volume Does Not Influence the Safety of Percutaneous Nephrolithotomy in England: A Population-Based Cohort Study.Withington JM, Charman SC, Armitage JN, Cromwell D, Finch WD, Wiseman OJ, Irving S, Glass J, Burgess NA.J Endourol. 2015 Aug;29(8):899-906. doi: 10.1089/end.2015.0007.

10. Would You Want to Be the Patient? “Live Surgical Broadcast” or “As-Live Unedited Surgical Broadcast”.

Finch W, Masood J, Buchholz N, Turney BW, Smith D, Wiseman O.

J Endourol. 2015 Jul;29(7):821-9. doi: 10.1089/end.2014.0580.

 

11. Use of the probability of stone formation (PSF) score to assess stone forming risk and treatment response in a cohort of Brazilian stone formers.

Turney B, Robertson W, Wiseman O, Amaro CR, Leitão VA, Silva IL, Amaro JL.

Int Braz J Urol. 2014 Jul-Aug;40(4):507-12. doi: 10.1590/S1677-5538.IBJU.2014.04.09.

 

12. Salvage of liver transplant with hepatolithiasis by percutaneous transhepatic cholangioscopic hepatolithotomy.

Ali JM, See TC, Wiseman O, Griffiths WJ, Jah A.

Transpl Int. 2014 Dec;27(12):e126-8. doi: 10.1111/tri.12387. 

 

13. ‘Measurement for improvement not judgement’ — the case of percutaneous nephrolithotomy.

Withington J, Armitage J, Finch W, Hughes B, Glass JM, Wiseman OJ, Irving SO, Burgess NA.

BJU Int. 2015 Feb;115(2):181-3. doi: 10.1111/bju.12660. 

The cookie setting on this website is set to ‘allow cookies’ to give you the very best experience.

If you continue without changing this setting, you consent to this - but if you want, you can change your setting at any time using the ‘change cookie setting’ link at the bottom of this page.

Cookie Setting







Our Cookies

Cookie NamePurpose
eu_ask This is used to store the cookie setting you set in the form above.
If you choose 'Do Not Allow Cookies' we will need to store this information as a cookie with the value N.
If you choose 'Allow Cookies' or do not make a choice, we will store this information as a cookie with the value Y.

The value is kept for one year.

3rd Party Cookies

Cookie NamePurpose
Google Analytics This website uses Google Analytics, a web analytics service provided by Google, Inc.
Google Analytics sets a cookie in order to evaluate your use of the website and compile reports for us on activity on the website.
Google stores the information collected by the cookie on servers in the United States.
Google may also transfer this information to third parties where required to do so by law,
or where such third parties process the information on Google's behalf.
Google will not associate your IP address with any other data held by Google
By using this website, you consent to the processing of data about you by Google in the manner and for the purposes set out above.

How to reject or delete this cookie

http://www.google.com/intl/en/privacypolicy.html